Variable | Total; N = 89 | Hashimoto Thyroiditis | P-value* | ||
---|---|---|---|---|---|
Yes; n = 50 | No; n = 39 | ||||
Gender; n (%) | Male | 13 (14.6) | 5 (10.0) | 8 (20.5) | 0.228 |
Female | 76 (85.4) | 45 (90.0) | 31 (79.5) | ||
Age (years); mean ± SD | 38.08 ± 13.72 | 36.36 ± 11.57 | 40.28 ± 15.95 | 0.182 | |
Tumor type; n (%) | Classic | 59 (66.3) | 35 (70.0) | 24 (61.5) | 0.402 |
Other | 30 (33.7) | 15 (30.0) | 15 (38.5) | ||
Tumor size; median [Q1 – Q3] | 13 [8–24] | 12.5 [8–20.25] | 17 [5–30] | 0.456 | |
Multifocality | Multifocal | 38 (42.7) | 13 (33.3) | 25 (50.0) | 0.135 |
Unifocal | 51 (57.3) | 25 (50.0) | 26 (66.7) | ||
Marginal invasion | Yes | 31 (34.8) | 18 (36.0) | 13 (33.3) | 0.793 |
No | 58 (65.2) | 32 (64.0) | 26 (66.7) | ||
Lymphovascular invasion | Yes | 11 (12.4) | 6 (12.0) | 5 (12.8) | 1.000 |
No | 78 (87.6) | 44 (88.0) | 34 (87.2) | ||
Perineural invasion | Yes | 4 (4.5) | 2 (4.0) | 2 (5.1) | 1.000 |
No | 85 (95.5) | 48 (96.0) | 37 (94.9) | ||
Extrathyroidal extension | Yes | 5 (5.6) | 2 (4.0) | 3 (7.7) | 0.650 |
No | 84 (94.4) | 48 (96.0) | 36 (92.3) | ||
Necrosis | Yes | 3 (3.4) | 1 (2.0) | 2 (5.1) | 0.579 |
No | 86 (96.6) | 49 (98.0) | 37 (94.9) | ||
Capsular invasion | Yes | 25 (28.1) | 15 (30.0) | 10 (25.6) | 0.813 |
No | 64 (71.9) | 35 (70.0) | 29 (74.4) | ||
Central LN involvement; median [Q1 – Q3] | 0 [0–1.5] | 0 [0–1] | 0 [0–2] | 0.227 |